nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—Methotrexate—hematologic cancer	0.057	0.0795	CbGbCtD
Proguanil—CYP1A2—Anagrelide—hematologic cancer	0.0339	0.0473	CbGbCtD
Proguanil—CYP2E1—Thalidomide—hematologic cancer	0.0217	0.0303	CbGbCtD
Proguanil—CYP2C9—Bexarotene—hematologic cancer	0.0212	0.0295	CbGbCtD
Proguanil—CYP2E1—Dacarbazine—hematologic cancer	0.0187	0.026	CbGbCtD
Proguanil—CYP2D6—Lomustine—hematologic cancer	0.018	0.0251	CbGbCtD
Proguanil—CYP1A2—Carmustine—hematologic cancer	0.0178	0.0248	CbGbCtD
Proguanil—CYP2C9—Idarubicin—hematologic cancer	0.0176	0.0245	CbGbCtD
Proguanil—CYP2D6—Idarubicin—hematologic cancer	0.0161	0.0224	CbGbCtD
Proguanil—CYP2C19—Bortezomib—hematologic cancer	0.0156	0.0218	CbGbCtD
Proguanil—CYP1A2—Methoxsalen—hematologic cancer	0.0152	0.0211	CbGbCtD
Proguanil—CYP2E1—Mitoxantrone—hematologic cancer	0.0145	0.0202	CbGbCtD
Proguanil—CYP1A2—Bortezomib—hematologic cancer	0.0144	0.0201	CbGbCtD
Proguanil—CYP1A2—Daunorubicin—hematologic cancer	0.0138	0.0192	CbGbCtD
Proguanil—CYP2D6—Hydroxyurea—hematologic cancer	0.0136	0.019	CbGbCtD
Proguanil—CYP2C19—Thalidomide—hematologic cancer	0.0136	0.019	CbGbCtD
Proguanil—CYP1A2—Alitretinoin—hematologic cancer	0.0135	0.0188	CbGbCtD
Proguanil—CYP2C9—Bortezomib—hematologic cancer	0.013	0.0181	CbGbCtD
Proguanil—CYP2C19—Teniposide—hematologic cancer	0.013	0.0181	CbGbCtD
Proguanil—CYP1A2—Thalidomide—hematologic cancer	0.0126	0.0175	CbGbCtD
Proguanil—CYP3A4—Bexarotene—hematologic cancer	0.0123	0.0172	CbGbCtD
Proguanil—CYP2C19—Ifosfamide—hematologic cancer	0.012	0.0167	CbGbCtD
Proguanil—CYP2D6—Bortezomib—hematologic cancer	0.0119	0.0165	CbGbCtD
Proguanil—CYP3A4—Lomustine—hematologic cancer	0.0115	0.016	CbGbCtD
Proguanil—CYP3A4—Busulfan—hematologic cancer	0.0115	0.016	CbGbCtD
Proguanil—CYP2C19—Imatinib—hematologic cancer	0.0114	0.0159	CbGbCtD
Proguanil—CYP2C9—Thalidomide—hematologic cancer	0.0113	0.0158	CbGbCtD
Proguanil—CYP1A2—Dacarbazine—hematologic cancer	0.0108	0.015	CbGbCtD
Proguanil—CYP2C9—Teniposide—hematologic cancer	0.0108	0.015	CbGbCtD
Proguanil—CYP1A2—Imatinib—hematologic cancer	0.0106	0.0147	CbGbCtD
Proguanil—CYP3A4—Thiotepa—hematologic cancer	0.0102	0.0142	CbGbCtD
Proguanil—CYP2C9—Ifosfamide—hematologic cancer	0.00996	0.0139	CbGbCtD
Proguanil—CYP2C9—Imatinib—hematologic cancer	0.00951	0.0133	CbGbCtD
Proguanil—CYP2E1—Etoposide—hematologic cancer	0.00913	0.0127	CbGbCtD
Proguanil—CYP2D6—Imatinib—hematologic cancer	0.0087	0.0121	CbGbCtD
Proguanil—CYP2C9—Nilotinib—hematologic cancer	0.00865	0.012	CbGbCtD
Proguanil—CYP1A2—Dasatinib—hematologic cancer	0.00848	0.0118	CbGbCtD
Proguanil—CYP3A4—Methoxsalen—hematologic cancer	0.00794	0.0111	CbGbCtD
Proguanil—CYP2D6—Nilotinib—hematologic cancer	0.00791	0.011	CbGbCtD
Proguanil—CYP2D6—Vinorelbine—hematologic cancer	0.00784	0.0109	CbGbCtD
Proguanil—CYP3A4—Bortezomib—hematologic cancer	0.00755	0.0105	CbGbCtD
Proguanil—CYP2C19—Prednisone—hematologic cancer	0.00754	0.0105	CbGbCtD
Proguanil—CYP2E1—Dexamethasone—hematologic cancer	0.00751	0.0105	CbGbCtD
Proguanil—CYP3A4—Daunorubicin—hematologic cancer	0.00722	0.0101	CbGbCtD
Proguanil—CYP3A4—Cytarabine—hematologic cancer	0.00637	0.00888	CbGbCtD
Proguanil—CYP3A4—Teniposide—hematologic cancer	0.00627	0.00875	CbGbCtD
Proguanil—CYP3A4—Ifosfamide—hematologic cancer	0.00579	0.00807	CbGbCtD
Proguanil—CYP3A4—Imatinib—hematologic cancer	0.00553	0.00771	CbGbCtD
Proguanil—CYP1A2—Etoposide—hematologic cancer	0.00528	0.00736	CbGbCtD
Proguanil—CYP3A4—Ruxolitinib—hematologic cancer	0.00521	0.00726	CbGbCtD
Proguanil—CYP3A4—Nilotinib—hematologic cancer	0.00503	0.00701	CbGbCtD
Proguanil—CYP3A4—Vinorelbine—hematologic cancer	0.00498	0.00695	CbGbCtD
Proguanil—CYP2C9—Cisplatin—hematologic cancer	0.00484	0.00675	CbGbCtD
Proguanil—CYP2D6—Vinblastine—hematologic cancer	0.00483	0.00673	CbGbCtD
Proguanil—CYP2C19—Dexamethasone—hematologic cancer	0.00471	0.00656	CbGbCtD
Proguanil—CYP3A4—Triamcinolone—hematologic cancer	0.00456	0.00635	CbGbCtD
Proguanil—CYP3A4—Dasatinib—hematologic cancer	0.00444	0.00619	CbGbCtD
Proguanil—CYP3A4—Mitoxantrone—hematologic cancer	0.00439	0.00612	CbGbCtD
Proguanil—CYP2C9—Dexamethasone—hematologic cancer	0.00391	0.00545	CbGbCtD
Proguanil—CYP3A4—Betamethasone—hematologic cancer	0.00391	0.00545	CbGbCtD
Proguanil—CYP3A4—Prednisolone—hematologic cancer	0.00386	0.00538	CbGbCtD
Proguanil—CYP3A4—Prednisone—hematologic cancer	0.00364	0.00508	CbGbCtD
Proguanil—CYP2D6—Dexamethasone—hematologic cancer	0.00358	0.00499	CbGbCtD
Proguanil—CYP3A4—Irinotecan—hematologic cancer	0.00346	0.00482	CbGbCtD
Proguanil—CYP3A4—Vinblastine—hematologic cancer	0.00307	0.00428	CbGbCtD
Proguanil—CYP3A4—Vincristine—hematologic cancer	0.00302	0.00421	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—hematologic cancer	0.00297	0.00414	CbGbCtD
Proguanil—CYP3A4—Etoposide—hematologic cancer	0.00277	0.00386	CbGbCtD
Proguanil—CYP3A4—Dexamethasone—hematologic cancer	0.00228	0.00317	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—hematologic cancer	0.00189	0.00263	CbGbCtD
Proguanil—DHFR—hematopoietic system—hematologic cancer	0.00137	0.102	CbGeAlD
Proguanil—DHFR—gonad—hematologic cancer	0.00104	0.0779	CbGeAlD
Proguanil—DHFR—blood—hematologic cancer	0.000906	0.0678	CbGeAlD
Proguanil—DHFR—bone marrow—hematologic cancer	0.000876	0.0656	CbGeAlD
Proguanil—DHFR—lung—hematologic cancer	0.000794	0.0595	CbGeAlD
Proguanil—CYP2C19—hematopoietic system—hematologic cancer	0.000778	0.0582	CbGeAlD
Proguanil—DHFR—testis—hematologic cancer	0.000749	0.0561	CbGeAlD
Proguanil—CYP1A2—hematopoietic system—hematologic cancer	0.000635	0.0476	CbGeAlD
Proguanil—CYP2C9—hematopoietic system—hematologic cancer	0.000603	0.0452	CbGeAlD
Proguanil—CYP2E1—hematopoietic system—hematologic cancer	0.000571	0.0428	CbGeAlD
Proguanil—DHFR—lymph node—hematologic cancer	0.000543	0.0407	CbGeAlD
Proguanil—CYP2C19—blood—hematologic cancer	0.000515	0.0386	CbGeAlD
Proguanil—CYP3A4—hematopoietic system—hematologic cancer	0.00046	0.0344	CbGeAlD
Proguanil—CYP2D6—hematopoietic system—hematologic cancer	0.000452	0.0339	CbGeAlD
Proguanil—CYP1A2—blood—hematologic cancer	0.000421	0.0315	CbGeAlD
Proguanil—CYP2C9—blood—hematologic cancer	0.000399	0.0299	CbGeAlD
Proguanil—CYP2E1—blood—hematologic cancer	0.000379	0.0283	CbGeAlD
Proguanil—CYP1A2—lung—hematologic cancer	0.000369	0.0276	CbGeAlD
Proguanil—CYP2E1—lung—hematologic cancer	0.000332	0.0249	CbGeAlD
Proguanil—CYP2E1—testis—hematologic cancer	0.000313	0.0234	CbGeAlD
Proguanil—CYP3A4—blood—hematologic cancer	0.000305	0.0228	CbGeAlD
Proguanil—CYP2D6—blood—hematologic cancer	0.0003	0.0224	CbGeAlD
Proguanil—CYP2D6—testis—hematologic cancer	0.000248	0.0186	CbGeAlD
Proguanil—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000138	0.000696	CcSEcCtD
Proguanil—Vomiting—Lenalidomide—hematologic cancer	0.000138	0.000694	CcSEcCtD
Proguanil—Rash—Lenalidomide—hematologic cancer	0.000137	0.000688	CcSEcCtD
Proguanil—Abdominal pain—Carmustine—hematologic cancer	0.000137	0.000687	CcSEcCtD
Proguanil—Body temperature increased—Carmustine—hematologic cancer	0.000137	0.000687	CcSEcCtD
Proguanil—Dermatitis—Lenalidomide—hematologic cancer	0.000137	0.000687	CcSEcCtD
Proguanil—Diarrhoea—Bortezomib—hematologic cancer	0.000137	0.000687	CcSEcCtD
Proguanil—Decreased appetite—Gemcitabine—hematologic cancer	0.000136	0.000685	CcSEcCtD
Proguanil—Vomiting—Hydroxyurea—hematologic cancer	0.000136	0.000684	CcSEcCtD
Proguanil—Headache—Lenalidomide—hematologic cancer	0.000136	0.000683	CcSEcCtD
Proguanil—Body temperature increased—Alitretinoin—hematologic cancer	0.000135	0.000681	CcSEcCtD
Proguanil—Abdominal pain—Alitretinoin—hematologic cancer	0.000135	0.000681	CcSEcCtD
Proguanil—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000135	0.00068	CcSEcCtD
Proguanil—Gastrointestinal pain—Vincristine—hematologic cancer	0.000135	0.000679	CcSEcCtD
Proguanil—Rash—Hydroxyurea—hematologic cancer	0.000135	0.000678	CcSEcCtD
Proguanil—Erythema—Betamethasone—hematologic cancer	0.000135	0.000678	CcSEcCtD
Proguanil—Erythema—Dexamethasone—hematologic cancer	0.000135	0.000678	CcSEcCtD
Proguanil—Dermatitis—Hydroxyurea—hematologic cancer	0.000135	0.000678	CcSEcCtD
Proguanil—Hallucination—Prednisone—hematologic cancer	0.000134	0.000675	CcSEcCtD
Proguanil—Headache—Hydroxyurea—hematologic cancer	0.000134	0.000674	CcSEcCtD
Proguanil—Abdominal pain—Ifosfamide—hematologic cancer	0.000134	0.000673	CcSEcCtD
Proguanil—Body temperature increased—Ifosfamide—hematologic cancer	0.000134	0.000673	CcSEcCtD
Proguanil—Pancytopenia—Methotrexate—hematologic cancer	0.000134	0.000673	CcSEcCtD
Proguanil—Diarrhoea—Vinorelbine—hematologic cancer	0.000133	0.000671	CcSEcCtD
Proguanil—Nausea—Melphalan—hematologic cancer	0.000133	0.000666	CcSEcCtD
Proguanil—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000131	0.000661	CcSEcCtD
Proguanil—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000131	0.000661	CcSEcCtD
Proguanil—Body temperature increased—Vincristine—hematologic cancer	0.00013	0.000656	CcSEcCtD
Proguanil—Abdominal pain—Vincristine—hematologic cancer	0.00013	0.000656	CcSEcCtD
Proguanil—Skin disorder—Etoposide—hematologic cancer	0.00013	0.000653	CcSEcCtD
Proguanil—Cough—Triamcinolone—hematologic cancer	0.00013	0.000652	CcSEcCtD
Proguanil—Nausea—Lenalidomide—hematologic cancer	0.000129	0.000648	CcSEcCtD
Proguanil—Anorexia—Etoposide—hematologic cancer	0.000127	0.000641	CcSEcCtD
Proguanil—Diarrhoea—Thiotepa—hematologic cancer	0.000127	0.000641	CcSEcCtD
Proguanil—Abdominal pain—Irinotecan—hematologic cancer	0.000127	0.000639	CcSEcCtD
Proguanil—Body temperature increased—Irinotecan—hematologic cancer	0.000127	0.000639	CcSEcCtD
Proguanil—Abdominal pain—Mitoxantrone—hematologic cancer	0.000127	0.000639	CcSEcCtD
Proguanil—Body temperature increased—Mitoxantrone—hematologic cancer	0.000127	0.000639	CcSEcCtD
Proguanil—Nausea—Hydroxyurea—hematologic cancer	0.000127	0.000639	CcSEcCtD
Proguanil—Vomiting—Bortezomib—hematologic cancer	0.000127	0.000638	CcSEcCtD
Proguanil—Decreased appetite—Cisplatin—hematologic cancer	0.000127	0.000638	CcSEcCtD
Proguanil—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000126	0.000634	CcSEcCtD
Proguanil—Vomiting—Bleomycin—hematologic cancer	0.000126	0.000633	CcSEcCtD
Proguanil—Rash—Bortezomib—hematologic cancer	0.000126	0.000633	CcSEcCtD
Proguanil—Dermatitis—Bortezomib—hematologic cancer	0.000126	0.000632	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—hematologic cancer	0.000125	0.000629	CcSEcCtD
Proguanil—Headache—Bortezomib—hematologic cancer	0.000125	0.000629	CcSEcCtD
Proguanil—Rash—Bleomycin—hematologic cancer	0.000125	0.000628	CcSEcCtD
Proguanil—Dermatitis—Bleomycin—hematologic cancer	0.000125	0.000628	CcSEcCtD
Proguanil—Vomiting—Vinorelbine—hematologic cancer	0.000124	0.000623	CcSEcCtD
Proguanil—Body temperature increased—Gemcitabine—hematologic cancer	0.000124	0.000623	CcSEcCtD
Proguanil—Diarrhoea—Thalidomide—hematologic cancer	0.000123	0.00062	CcSEcCtD
Proguanil—Rash—Vinorelbine—hematologic cancer	0.000123	0.000618	CcSEcCtD
Proguanil—Dermatitis—Vinorelbine—hematologic cancer	0.000123	0.000617	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—hematologic cancer	0.000122	0.000616	CcSEcCtD
Proguanil—Headache—Vinorelbine—hematologic cancer	0.000122	0.000614	CcSEcCtD
Proguanil—Immune system disorder—Prednisone—hematologic cancer	0.000122	0.000613	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—hematologic cancer	0.000119	0.000597	CcSEcCtD
Proguanil—Nausea—Bortezomib—hematologic cancer	0.000119	0.000596	CcSEcCtD
Proguanil—Vomiting—Thiotepa—hematologic cancer	0.000118	0.000595	CcSEcCtD
Proguanil—Diarrhoea—Carmustine—hematologic cancer	0.000118	0.000595	CcSEcCtD
Proguanil—Mental disorder—Prednisone—hematologic cancer	0.000118	0.000594	CcSEcCtD
Proguanil—Nausea—Bleomycin—hematologic cancer	0.000118	0.000592	CcSEcCtD
Proguanil—Erythema—Prednisone—hematologic cancer	0.000117	0.000591	CcSEcCtD
Proguanil—Malnutrition—Prednisone—hematologic cancer	0.000117	0.000591	CcSEcCtD
Proguanil—Rash—Thiotepa—hematologic cancer	0.000117	0.00059	CcSEcCtD
Proguanil—Dermatitis—Thiotepa—hematologic cancer	0.000117	0.00059	CcSEcCtD
Proguanil—Diarrhoea—Alitretinoin—hematologic cancer	0.000117	0.000589	CcSEcCtD
Proguanil—Headache—Thiotepa—hematologic cancer	0.000117	0.000586	CcSEcCtD
Proguanil—Decreased appetite—Etoposide—hematologic cancer	0.000116	0.000585	CcSEcCtD
Proguanil—Diarrhoea—Ifosfamide—hematologic cancer	0.000116	0.000583	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—hematologic cancer	0.000116	0.000582	CcSEcCtD
Proguanil—Nausea—Vinorelbine—hematologic cancer	0.000116	0.000582	CcSEcCtD
Proguanil—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000115	0.000581	CcSEcCtD
Proguanil—Body temperature increased—Cisplatin—hematologic cancer	0.000115	0.00058	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—hematologic cancer	0.000115	0.000576	CcSEcCtD
Proguanil—Vomiting—Thalidomide—hematologic cancer	0.000114	0.000576	CcSEcCtD
Proguanil—Rash—Thalidomide—hematologic cancer	0.000114	0.000571	CcSEcCtD
Proguanil—Dermatitis—Thalidomide—hematologic cancer	0.000113	0.00057	CcSEcCtD
Proguanil—Diarrhoea—Vincristine—hematologic cancer	0.000113	0.000568	CcSEcCtD
Proguanil—Headache—Thalidomide—hematologic cancer	0.000113	0.000567	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—hematologic cancer	0.000111	0.000559	CcSEcCtD
Proguanil—Nausea—Thiotepa—hematologic cancer	0.000111	0.000556	CcSEcCtD
Proguanil—Diarrhoea—Mitoxantrone—hematologic cancer	0.00011	0.000553	CcSEcCtD
Proguanil—Diarrhoea—Irinotecan—hematologic cancer	0.00011	0.000553	CcSEcCtD
Proguanil—Vomiting—Carmustine—hematologic cancer	0.00011	0.000553	CcSEcCtD
Proguanil—Gastrointestinal pain—Etoposide—hematologic cancer	0.000109	0.00055	CcSEcCtD
Proguanil—Rash—Carmustine—hematologic cancer	0.000109	0.000548	CcSEcCtD
Proguanil—Dermatitis—Carmustine—hematologic cancer	0.000109	0.000548	CcSEcCtD
Proguanil—Vomiting—Alitretinoin—hematologic cancer	0.000109	0.000548	CcSEcCtD
Proguanil—Headache—Carmustine—hematologic cancer	0.000108	0.000545	CcSEcCtD
Proguanil—Rash—Alitretinoin—hematologic cancer	0.000108	0.000543	CcSEcCtD
Proguanil—Nervous system disorder—Betamethasone—hematologic cancer	0.000108	0.000543	CcSEcCtD
Proguanil—Nervous system disorder—Dexamethasone—hematologic cancer	0.000108	0.000543	CcSEcCtD
Proguanil—Dermatitis—Alitretinoin—hematologic cancer	0.000108	0.000543	CcSEcCtD
Proguanil—Vomiting—Ifosfamide—hematologic cancer	0.000108	0.000541	CcSEcCtD
Proguanil—Headache—Alitretinoin—hematologic cancer	0.000107	0.00054	CcSEcCtD
Proguanil—Diarrhoea—Gemcitabine—hematologic cancer	0.000107	0.000539	CcSEcCtD
Proguanil—Nausea—Thalidomide—hematologic cancer	0.000107	0.000538	CcSEcCtD
Proguanil—Rash—Ifosfamide—hematologic cancer	0.000107	0.000537	CcSEcCtD
Proguanil—Dermatitis—Ifosfamide—hematologic cancer	0.000107	0.000536	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—hematologic cancer	0.000106	0.000533	CcSEcCtD
Proguanil—Abdominal pain—Etoposide—hematologic cancer	0.000106	0.000532	CcSEcCtD
Proguanil—Body temperature increased—Etoposide—hematologic cancer	0.000106	0.000532	CcSEcCtD
Proguanil—Vomiting—Vincristine—hematologic cancer	0.000105	0.000528	CcSEcCtD
Proguanil—Anorexia—Dexamethasone—hematologic cancer	0.000105	0.000528	CcSEcCtD
Proguanil—Anorexia—Betamethasone—hematologic cancer	0.000105	0.000528	CcSEcCtD
Proguanil—Rash—Vincristine—hematologic cancer	0.000104	0.000523	CcSEcCtD
Proguanil—Dermatitis—Vincristine—hematologic cancer	0.000104	0.000523	CcSEcCtD
Proguanil—Headache—Vincristine—hematologic cancer	0.000103	0.00052	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—hematologic cancer	0.000103	0.000517	CcSEcCtD
Proguanil—Nausea—Carmustine—hematologic cancer	0.000103	0.000517	CcSEcCtD
Proguanil—Vomiting—Mitoxantrone—hematologic cancer	0.000102	0.000514	CcSEcCtD
Proguanil—Vomiting—Irinotecan—hematologic cancer	0.000102	0.000514	CcSEcCtD
Proguanil—Immune system disorder—Methotrexate—hematologic cancer	0.000102	0.000512	CcSEcCtD
Proguanil—Nausea—Alitretinoin—hematologic cancer	0.000102	0.000512	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—hematologic cancer	0.000102	0.000511	CcSEcCtD
Proguanil—Rash—Irinotecan—hematologic cancer	0.000101	0.00051	CcSEcCtD
Proguanil—Rash—Mitoxantrone—hematologic cancer	0.000101	0.00051	CcSEcCtD
Proguanil—Dermatitis—Mitoxantrone—hematologic cancer	0.000101	0.000509	CcSEcCtD
Proguanil—Dermatitis—Irinotecan—hematologic cancer	0.000101	0.000509	CcSEcCtD
Proguanil—Headache—Irinotecan—hematologic cancer	0.000101	0.000506	CcSEcCtD
Proguanil—Headache—Mitoxantrone—hematologic cancer	0.000101	0.000506	CcSEcCtD
Proguanil—Nausea—Ifosfamide—hematologic cancer	0.000101	0.000506	CcSEcCtD
Proguanil—Diarrhoea—Cisplatin—hematologic cancer	9.99e-05	0.000502	CcSEcCtD
Proguanil—Vomiting—Gemcitabine—hematologic cancer	9.96e-05	0.000501	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.93e-05	0.000499	CcSEcCtD
Proguanil—Mental disorder—Methotrexate—hematologic cancer	9.88e-05	0.000497	CcSEcCtD
Proguanil—Rash—Gemcitabine—hematologic cancer	9.87e-05	0.000497	CcSEcCtD
Proguanil—Dermatitis—Gemcitabine—hematologic cancer	9.86e-05	0.000496	CcSEcCtD
Proguanil—Erythema—Methotrexate—hematologic cancer	9.81e-05	0.000494	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—hematologic cancer	9.81e-05	0.000494	CcSEcCtD
Proguanil—Headache—Gemcitabine—hematologic cancer	9.81e-05	0.000493	CcSEcCtD
Proguanil—Nausea—Vincristine—hematologic cancer	9.81e-05	0.000493	CcSEcCtD
Proguanil—Body temperature increased—Triamcinolone—hematologic cancer	9.59e-05	0.000482	CcSEcCtD
Proguanil—Decreased appetite—Dexamethasone—hematologic cancer	9.57e-05	0.000481	CcSEcCtD
Proguanil—Decreased appetite—Betamethasone—hematologic cancer	9.57e-05	0.000481	CcSEcCtD
Proguanil—Nausea—Irinotecan—hematologic cancer	9.55e-05	0.00048	CcSEcCtD
Proguanil—Nausea—Mitoxantrone—hematologic cancer	9.55e-05	0.00048	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—hematologic cancer	9.53e-05	0.000479	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—hematologic cancer	9.51e-05	0.000478	CcSEcCtD
Proguanil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.5e-05	0.000478	CcSEcCtD
Proguanil—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.5e-05	0.000478	CcSEcCtD
Proguanil—Nervous system disorder—Prednisone—hematologic cancer	9.4e-05	0.000473	CcSEcCtD
Proguanil—Skin disorder—Prednisone—hematologic cancer	9.31e-05	0.000468	CcSEcCtD
Proguanil—Nausea—Gemcitabine—hematologic cancer	9.3e-05	0.000468	CcSEcCtD
Proguanil—Vomiting—Cisplatin—hematologic cancer	9.28e-05	0.000467	CcSEcCtD
Proguanil—Mental disorder—Epirubicin—hematologic cancer	9.24e-05	0.000465	CcSEcCtD
Proguanil—Rash—Cisplatin—hematologic cancer	9.2e-05	0.000463	CcSEcCtD
Proguanil—Dermatitis—Cisplatin—hematologic cancer	9.19e-05	0.000462	CcSEcCtD
Proguanil—Erythema—Epirubicin—hematologic cancer	9.18e-05	0.000462	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—hematologic cancer	9.18e-05	0.000462	CcSEcCtD
Proguanil—Diarrhoea—Etoposide—hematologic cancer	9.15e-05	0.00046	CcSEcCtD
Proguanil—Anorexia—Prednisone—hematologic cancer	9.14e-05	0.000459	CcSEcCtD
Proguanil—Gastrointestinal pain—Betamethasone—hematologic cancer	9e-05	0.000453	CcSEcCtD
Proguanil—Gastrointestinal pain—Dexamethasone—hematologic cancer	9e-05	0.000453	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—hematologic cancer	8.82e-05	0.000443	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—hematologic cancer	8.8e-05	0.000442	CcSEcCtD
Proguanil—Abdominal pain—Betamethasone—hematologic cancer	8.7e-05	0.000437	CcSEcCtD
Proguanil—Body temperature increased—Dexamethasone—hematologic cancer	8.7e-05	0.000437	CcSEcCtD
Proguanil—Body temperature increased—Betamethasone—hematologic cancer	8.7e-05	0.000437	CcSEcCtD
Proguanil—Abdominal pain—Dexamethasone—hematologic cancer	8.7e-05	0.000437	CcSEcCtD
Proguanil—Nausea—Cisplatin—hematologic cancer	8.67e-05	0.000436	CcSEcCtD
Proguanil—Cough—Methotrexate—hematologic cancer	8.56e-05	0.000431	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—hematologic cancer	8.55e-05	0.00043	CcSEcCtD
Proguanil—Vomiting—Etoposide—hematologic cancer	8.5e-05	0.000428	CcSEcCtD
Proguanil—Erythema—Doxorubicin—hematologic cancer	8.5e-05	0.000427	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—hematologic cancer	8.5e-05	0.000427	CcSEcCtD
Proguanil—Rash—Etoposide—hematologic cancer	8.43e-05	0.000424	CcSEcCtD
Proguanil—Dermatitis—Etoposide—hematologic cancer	8.42e-05	0.000424	CcSEcCtD
Proguanil—Headache—Etoposide—hematologic cancer	8.38e-05	0.000421	CcSEcCtD
Proguanil—Decreased appetite—Prednisone—hematologic cancer	8.33e-05	0.000419	CcSEcCtD
Proguanil—Rash—Prednisolone—hematologic cancer	8.32e-05	0.000418	CcSEcCtD
Proguanil—Dermatitis—Prednisolone—hematologic cancer	8.31e-05	0.000418	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.3e-05	0.000417	CcSEcCtD
Proguanil—Headache—Prednisolone—hematologic cancer	8.26e-05	0.000416	CcSEcCtD
Proguanil—Cough—Epirubicin—hematologic cancer	8.01e-05	0.000403	CcSEcCtD
Proguanil—Nausea—Etoposide—hematologic cancer	7.94e-05	0.000399	CcSEcCtD
Proguanil—Nervous system disorder—Methotrexate—hematologic cancer	7.85e-05	0.000395	CcSEcCtD
Proguanil—Gastrointestinal pain—Prednisone—hematologic cancer	7.84e-05	0.000394	CcSEcCtD
Proguanil—Nausea—Prednisolone—hematologic cancer	7.83e-05	0.000394	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—hematologic cancer	7.78e-05	0.000391	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.77e-05	0.000391	CcSEcCtD
Proguanil—Vomiting—Triamcinolone—hematologic cancer	7.71e-05	0.000388	CcSEcCtD
Proguanil—Rash—Triamcinolone—hematologic cancer	7.65e-05	0.000385	CcSEcCtD
Proguanil—Dermatitis—Triamcinolone—hematologic cancer	7.64e-05	0.000384	CcSEcCtD
Proguanil—Anorexia—Methotrexate—hematologic cancer	7.63e-05	0.000384	CcSEcCtD
Proguanil—Headache—Triamcinolone—hematologic cancer	7.6e-05	0.000382	CcSEcCtD
Proguanil—Body temperature increased—Prednisone—hematologic cancer	7.58e-05	0.000381	CcSEcCtD
Proguanil—Abdominal pain—Prednisone—hematologic cancer	7.58e-05	0.000381	CcSEcCtD
Proguanil—Diarrhoea—Betamethasone—hematologic cancer	7.53e-05	0.000379	CcSEcCtD
Proguanil—Diarrhoea—Dexamethasone—hematologic cancer	7.53e-05	0.000379	CcSEcCtD
Proguanil—Cough—Doxorubicin—hematologic cancer	7.42e-05	0.000373	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—hematologic cancer	7.35e-05	0.00037	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—hematologic cancer	7.28e-05	0.000366	CcSEcCtD
Proguanil—Nausea—Triamcinolone—hematologic cancer	7.2e-05	0.000362	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.19e-05	0.000361	CcSEcCtD
Proguanil—Anorexia—Epirubicin—hematologic cancer	7.14e-05	0.000359	CcSEcCtD
Proguanil—Vomiting—Betamethasone—hematologic cancer	7e-05	0.000352	CcSEcCtD
Proguanil—Vomiting—Dexamethasone—hematologic cancer	7e-05	0.000352	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—hematologic cancer	6.96e-05	0.00035	CcSEcCtD
Proguanil—Rash—Dexamethasone—hematologic cancer	6.94e-05	0.000349	CcSEcCtD
Proguanil—Rash—Betamethasone—hematologic cancer	6.94e-05	0.000349	CcSEcCtD
Proguanil—Dermatitis—Dexamethasone—hematologic cancer	6.93e-05	0.000349	CcSEcCtD
Proguanil—Dermatitis—Betamethasone—hematologic cancer	6.93e-05	0.000349	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.91e-05	0.000348	CcSEcCtD
Proguanil—Headache—Betamethasone—hematologic cancer	6.89e-05	0.000347	CcSEcCtD
Proguanil—Headache—Dexamethasone—hematologic cancer	6.89e-05	0.000347	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—hematologic cancer	6.8e-05	0.000342	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—hematologic cancer	6.74e-05	0.000339	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—hematologic cancer	6.61e-05	0.000332	CcSEcCtD
Proguanil—Diarrhoea—Prednisone—hematologic cancer	6.56e-05	0.00033	CcSEcCtD
Proguanil—Gastrointestinal pain—Methotrexate—hematologic cancer	6.55e-05	0.000329	CcSEcCtD
Proguanil—Nausea—Dexamethasone—hematologic cancer	6.54e-05	0.000329	CcSEcCtD
Proguanil—Nausea—Betamethasone—hematologic cancer	6.54e-05	0.000329	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—hematologic cancer	6.52e-05	0.000328	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.47e-05	0.000325	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—hematologic cancer	6.33e-05	0.000318	CcSEcCtD
Proguanil—Body temperature increased—Methotrexate—hematologic cancer	6.33e-05	0.000318	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—hematologic cancer	6.13e-05	0.000308	CcSEcCtD
Proguanil—Vomiting—Prednisone—hematologic cancer	6.09e-05	0.000306	CcSEcCtD
Proguanil—Rash—Prednisone—hematologic cancer	6.04e-05	0.000304	CcSEcCtD
Proguanil—Dermatitis—Prednisone—hematologic cancer	6.04e-05	0.000304	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—hematologic cancer	6.03e-05	0.000303	CcSEcCtD
Proguanil—Headache—Prednisone—hematologic cancer	6e-05	0.000302	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.99e-05	0.000301	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—hematologic cancer	5.93e-05	0.000298	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—hematologic cancer	5.93e-05	0.000298	CcSEcCtD
Proguanil—Nausea—Prednisone—hematologic cancer	5.69e-05	0.000286	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.67e-05	0.000285	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—hematologic cancer	5.48e-05	0.000276	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—hematologic cancer	5.48e-05	0.000276	CcSEcCtD
Proguanil—Diarrhoea—Methotrexate—hematologic cancer	5.48e-05	0.000276	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—hematologic cancer	5.13e-05	0.000258	CcSEcCtD
Proguanil—Vomiting—Methotrexate—hematologic cancer	5.09e-05	0.000256	CcSEcCtD
Proguanil—Rash—Methotrexate—hematologic cancer	5.05e-05	0.000254	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—hematologic cancer	5.05e-05	0.000254	CcSEcCtD
Proguanil—Headache—Methotrexate—hematologic cancer	5.02e-05	0.000252	CcSEcCtD
Proguanil—Vomiting—Epirubicin—hematologic cancer	4.77e-05	0.00024	CcSEcCtD
Proguanil—Nausea—Methotrexate—hematologic cancer	4.76e-05	0.000239	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—hematologic cancer	4.75e-05	0.000239	CcSEcCtD
Proguanil—Rash—Epirubicin—hematologic cancer	4.73e-05	0.000238	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—hematologic cancer	4.72e-05	0.000237	CcSEcCtD
Proguanil—Headache—Epirubicin—hematologic cancer	4.7e-05	0.000236	CcSEcCtD
Proguanil—Nausea—Epirubicin—hematologic cancer	4.45e-05	0.000224	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—hematologic cancer	4.41e-05	0.000222	CcSEcCtD
Proguanil—Rash—Doxorubicin—hematologic cancer	4.37e-05	0.00022	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—hematologic cancer	4.37e-05	0.00022	CcSEcCtD
Proguanil—Headache—Doxorubicin—hematologic cancer	4.34e-05	0.000218	CcSEcCtD
Proguanil—Nausea—Doxorubicin—hematologic cancer	4.12e-05	0.000207	CcSEcCtD
Proguanil—CYP2D6—Metabolism—GSTO1—hematologic cancer	9.1e-06	0.000129	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCC3—hematologic cancer	9.1e-06	0.000129	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—IDH2—hematologic cancer	9.07e-06	0.000129	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HMMR—hematologic cancer	9.07e-06	0.000129	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC22A1—hematologic cancer	9.05e-06	0.000129	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CRABP1—hematologic cancer	9.05e-06	0.000129	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTO1—hematologic cancer	9.02e-06	0.000128	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TXN—hematologic cancer	9.02e-06	0.000128	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCC3—hematologic cancer	9.02e-06	0.000128	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SPHK1—hematologic cancer	8.91e-06	0.000127	CbGpPWpGaD
Proguanil—DHFR—Disease—MAPK3—hematologic cancer	8.89e-06	0.000126	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.83e-06	0.000125	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.82e-06	0.000125	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTEN—hematologic cancer	8.71e-06	0.000124	CbGpPWpGaD
Proguanil—DHFR—Disease—MYC—hematologic cancer	8.64e-06	0.000123	CbGpPWpGaD
Proguanil—DHFR—Disease—TGFB1—hematologic cancer	8.62e-06	0.000123	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—UGT1A1—hematologic cancer	8.56e-06	0.000122	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.55e-06	0.000122	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NUP98—hematologic cancer	8.54e-06	0.000121	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.53e-06	0.000121	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.48e-06	0.000121	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTAP—hematologic cancer	8.45e-06	0.00012	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.32e-06	0.000118	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.32e-06	0.000118	CbGpPWpGaD
Proguanil—DHFR—Metabolism—EP300—hematologic cancer	8.31e-06	0.000118	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CA9—hematologic cancer	8.29e-06	0.000118	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ACP5—hematologic cancer	8.29e-06	0.000118	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ADCY7—hematologic cancer	8.29e-06	0.000118	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOA3—hematologic cancer	8.29e-06	0.000118	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NQO1—hematologic cancer	8.26e-06	0.000117	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CD44—hematologic cancer	8.26e-06	0.000117	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CRABP1—hematologic cancer	8.25e-06	0.000117	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC22A1—hematologic cancer	8.25e-06	0.000117	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NUP214—hematologic cancer	8.23e-06	0.000117	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOR2—hematologic cancer	8.18e-06	0.000116	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.15e-06	0.000116	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.11e-06	0.000115	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MTR—hematologic cancer	8.07e-06	0.000115	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCG2—hematologic cancer	8.07e-06	0.000115	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALOX5—hematologic cancer	8.04e-06	0.000114	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—hematologic cancer	7.99e-06	0.000114	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ENO2—hematologic cancer	7.91e-06	0.000112	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NUP98—hematologic cancer	7.86e-06	0.000112	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYCS—hematologic cancer	7.82e-06	0.000111	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—IDH1—hematologic cancer	7.8e-06	0.000111	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NUP98—hematologic cancer	7.79e-06	0.000111	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	7.77e-06	0.00011	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TXN—hematologic cancer	7.71e-06	0.00011	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.71e-06	0.00011	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.71e-06	0.00011	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.67e-06	0.000109	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.63e-06	0.000108	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.63e-06	0.000108	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NUP214—hematologic cancer	7.57e-06	0.000108	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.56e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.56e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.55e-06	0.000107	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.54e-06	0.000107	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—FHL2—hematologic cancer	7.53e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NUP214—hematologic cancer	7.51e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SDC1—hematologic cancer	7.5e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.43e-06	0.000106	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.42e-06	0.000105	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MTR—hematologic cancer	7.42e-06	0.000105	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AGRN—hematologic cancer	7.38e-06	0.000105	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.35e-06	0.000105	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MTR—hematologic cancer	7.35e-06	0.000105	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CA—hematologic cancer	7.34e-06	0.000104	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ENO2—hematologic cancer	7.28e-06	0.000103	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—UGT1A1—hematologic cancer	7.25e-06	0.000103	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ENO2—hematologic cancer	7.21e-06	0.000103	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.16e-06	0.000102	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.07e-06	0.0001	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.06e-06	0.0001	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CRABP1—hematologic cancer	7.05e-06	0.0001	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC22A1—hematologic cancer	7.05e-06	0.0001	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HMMR—hematologic cancer	7e-06	9.95e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—IDH2—hematologic cancer	7e-06	9.95e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTT1—hematologic cancer	7e-06	9.94e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SDC1—hematologic cancer	6.9e-06	9.8e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTP1—hematologic cancer	6.89e-06	9.8e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.89e-06	9.79e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.87e-06	9.77e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SDC1—hematologic cancer	6.84e-06	9.72e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—hematologic cancer	6.79e-06	9.65e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.76e-06	9.61e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NUP98—hematologic cancer	6.66e-06	9.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.58e-06	9.35e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.53e-06	9.28e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ABCB1—hematologic cancer	6.52e-06	9.27e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—hematologic cancer	6.5e-06	9.23e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.46e-06	9.18e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.46e-06	9.18e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.45e-06	9.16e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NUP214—hematologic cancer	6.42e-06	9.12e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CA9—hematologic cancer	6.4e-06	9.1e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ACP5—hematologic cancer	6.4e-06	9.1e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CD44—hematologic cancer	6.38e-06	9.06e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NQO1—hematologic cancer	6.38e-06	9.06e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.35e-06	9.02e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NCOR1—hematologic cancer	6.33e-06	9e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—hematologic cancer	6.33e-06	9e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.32e-06	8.98e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCG2—hematologic cancer	6.28e-06	8.93e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTR—hematologic cancer	6.28e-06	8.93e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.24e-06	8.87e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.17e-06	8.77e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ENO2—hematologic cancer	6.16e-06	8.76e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—hematologic cancer	6.14e-06	8.73e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYCS—hematologic cancer	6.03e-06	8.57e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—IDH1—hematologic cancer	6.02e-06	8.55e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.99e-06	8.52e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—hematologic cancer	5.99e-06	8.52e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.98e-06	8.5e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TXN—hematologic cancer	5.95e-06	8.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.95e-06	8.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.95e-06	8.46e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.89e-06	8.37e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CD44—hematologic cancer	5.86e-06	8.33e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NQO1—hematologic cancer	5.86e-06	8.33e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SDC1—hematologic cancer	5.84e-06	8.3e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.82e-06	8.28e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CD44—hematologic cancer	5.81e-06	8.26e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NQO1—hematologic cancer	5.81e-06	8.26e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.69e-06	8.09e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—MTHFR—hematologic cancer	5.6e-06	7.96e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.59e-06	7.95e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.58e-06	7.93e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYCS—hematologic cancer	5.55e-06	7.89e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.51e-06	7.84e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.51e-06	7.83e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYCS—hematologic cancer	5.5e-06	7.82e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.47e-06	7.77e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.44e-06	7.73e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.44e-06	7.73e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.4e-06	7.67e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.32e-06	7.56e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.3e-06	7.54e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.27e-06	7.49e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.15e-06	7.31e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NUP98—hematologic cancer	5.14e-06	7.3e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCB1—hematologic cancer	5.03e-06	7.15e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—hematologic cancer	5.02e-06	7.13e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.99e-06	7.09e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.99e-06	7.09e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CD44—hematologic cancer	4.97e-06	7.06e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NQO1—hematologic cancer	4.97e-06	7.06e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NUP214—hematologic cancer	4.95e-06	7.04e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.92e-06	6.99e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.89e-06	6.95e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.89e-06	6.95e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.89e-06	6.95e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.86e-06	6.91e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTR—hematologic cancer	4.85e-06	6.89e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.85e-06	6.89e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.85e-06	6.89e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ENO2—hematologic cancer	4.76e-06	6.76e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CG—hematologic cancer	4.7e-06	6.68e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYCS—hematologic cancer	4.7e-06	6.68e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.69e-06	6.67e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.67e-06	6.64e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.63e-06	6.58e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.61e-06	6.56e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.59e-06	6.52e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SDC1—hematologic cancer	4.51e-06	6.41e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.49e-06	6.39e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.49e-06	6.39e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.46e-06	6.33e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.46e-06	6.33e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CREBBP—hematologic cancer	4.36e-06	6.2e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.32e-06	6.14e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.2e-06	5.97e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.14e-06	5.89e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CD—hematologic cancer	4.13e-06	5.88e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALB—hematologic cancer	4.08e-06	5.8e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.01e-06	5.7e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.97e-06	5.65e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.94e-06	5.6e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.92e-06	5.57e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.9e-06	5.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NQO1—hematologic cancer	3.83e-06	5.45e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CD44—hematologic cancer	3.83e-06	5.45e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.81e-06	5.41e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.81e-06	5.41e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.81e-06	5.41e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.63e-06	5.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYCS—hematologic cancer	3.63e-06	5.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.6e-06	5.12e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.6e-06	5.12e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.47e-06	4.93e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.37e-06	4.78e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.36e-06	4.78e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.34e-06	4.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.31e-06	4.7e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.2e-06	4.54e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.19e-06	4.53e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALB—hematologic cancer	3.15e-06	4.48e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—hematologic cancer	3.11e-06	4.43e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.09e-06	4.4e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.07e-06	4.36e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.03e-06	4.3e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.01e-06	4.28e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—EP300—hematologic cancer	2.97e-06	4.22e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.97e-06	4.21e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.94e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.94e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.93e-06	4.17e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.91e-06	4.13e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALB—hematologic cancer	2.9e-06	4.12e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALB—hematologic cancer	2.87e-06	4.08e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.83e-06	4.02e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.78e-06	3.95e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.77e-06	3.94e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.75e-06	3.9e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.62e-06	3.73e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.6e-06	3.69e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.56e-06	3.63e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.54e-06	3.6e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.49e-06	3.53e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALB—hematologic cancer	2.45e-06	3.49e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—hematologic cancer	2.4e-06	3.41e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.35e-06	3.34e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—EP300—hematologic cancer	2.29e-06	3.26e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—hematologic cancer	2.21e-06	3.14e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.2e-06	3.12e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—hematologic cancer	2.19e-06	3.11e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.18e-06	3.1e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.17e-06	3.08e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—EP300—hematologic cancer	2.11e-06	3e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—EP300—hematologic cancer	2.09e-06	2.97e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.02e-06	2.88e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.92e-06	2.73e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALB—hematologic cancer	1.89e-06	2.69e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—hematologic cancer	1.87e-06	2.66e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.81e-06	2.57e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—hematologic cancer	1.79e-06	2.55e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—EP300—hematologic cancer	1.79e-06	2.54e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.7e-06	2.41e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.67e-06	2.38e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.56e-06	2.22e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.55e-06	2.2e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—hematologic cancer	1.44e-06	2.05e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—hematologic cancer	1.38e-06	1.97e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—EP300—hematologic cancer	1.38e-06	1.96e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.32e-06	1.88e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—hematologic cancer	1.27e-06	1.81e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—hematologic cancer	1.26e-06	1.79e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—hematologic cancer	1.08e-06	1.53e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.02e-06	1.45e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—hematologic cancer	8.33e-07	1.18e-05	CbGpPWpGaD
